You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Next »

This project team will create a White Paper with recommendations for analyses and displays for laboratory data, with a focus on Phase 2-4 clinical trials and integrated submission documents.  There have been 2 previous White Papers on this topic (1 for central tendency in 2013 and 1 for outliers/shifts in 2015).  This White Paper will combine to two method types and update recommendations given the advancement in interactive options.

Project Lead:

Wei Wangwang_wei_v@lilly.com
  • No labels